Integrated Biopharma (INBP) CEO pay: $318,641 actually paid in FY2025
$INBP · INTEGRATED BIOPHARMA INCData through FY2025 — latest proxy filed 2025-10-28, checked for new filings 2026-08-21. Every number links to its source.
0.1× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2023 | Same, peer group since FY2023 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $325,037 | $318,641 | $333,380 | $72.00 | — | $808,000 |
| 2024 | $331,301 | $315,189 | $328,805 | $42.00 | — | $112,000 |
| 2023 | $306,742 | $296,143 | $320,194 | $66.00 | — | -$34,000 |
Frequently asked
How much did the INBP CEO make in 2025?
$318,641 in Compensation Actually Paid (CAP) as INTEGRATED BIOPHARMA INC's CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2025-10-28.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on INBP: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary